Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrases (CAs) are a family of zinc-containing metalloenzymes that catalyze the reversible hydration of carbon dioxide (CO2) to bicarbonate (HCO3-) and protons (H+). This reaction is fundamental for maintaining acid-base balance and facilitating CO2 transport in various physiological processes. There are at least 16 different CA isozymes identified in mammals, each with distinct tissue distributions, cellular localizations, and biophysical properties. Certain CA isozymes have been validated as therapeutic targets in glaucoma, stroke, and cancer.
Inhibition of carbonic anhydrase activity, preventing the conversion of CO2 to bicarbonate and protons.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase Isozyme (CA).